<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03290300</url>
  </required_header>
  <id_info>
    <org_study_id>TP465</org_study_id>
    <nct_id>NCT03290300</nct_id>
  </id_info>
  <brief_title>Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device</brief_title>
  <official_title>A Prospective, Multi-Center, Non-Randomized Study to Evaluate the Quality of Life Impact After Treatment of Nasal Airway Obstruction Using the Aerin Medical Vivaer Stylus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aerin Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aerin Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of long-term (2-year) quality of life after nasal airway obstruction treatment
      with the Aerin Vivaer Stylus
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, non-randomized, multi-center follow-up study to collect long term
      quality of life (QOL) data on a cohort of patients who participated in the Aerin Medical
      TP258 study &quot;A Prospective, Multi-Center, Non-Randomized Study to Evaluate Treatment of Nasal
      Airway Obstruction Using the Aerin Medical Device&quot;. The TP258 study followed subjects out to
      26 weeks post-procedure. This QOL study will collect data at 12, 18 and 24 months
      post-procedure.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 30, 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in NOSE score</measure>
    <time_frame>12, 18 and 24 months post-procedure</time_frame>
    <description>Mean change in Nasal Obstruction Symptom Evaluation (NOSE) score from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life Assessment</measure>
    <time_frame>12, 18 and 24 months post-procedure</time_frame>
    <description>Study-specific quality of life questionnaire</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Nasal Obstruction</condition>
  <arm_group>
    <arm_group_label>Long-Term Study Subjects</arm_group_label>
    <description>This cohort will consist of all subjects who were treated with the Vivaer Stylus in the 50-subject TP258 interventional study, who consent to continue to provide quality of life data.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vivaer Stylus</intervention_name>
    <description>Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus</description>
    <arm_group_label>Long-Term Study Subjects</arm_group_label>
    <other_name>Aerin Medical Device</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The subjects in this study will all have completed participation in the TP 258 Nasal
        Obstruction study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Received nasal obstruction treatment in Aerin Study TP 258

        Exclusion Criteria:

          -  Unwilling to participate in this long-term study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Wolf, MD</last_name>
    <role>Study Director</role>
    <affiliation>Aerin Medical</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ofer Jacobowitz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ENT and Allergy Associates, Middletown, NY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central California Clinical Research</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado ENT and Allergy</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates, LLP</name>
      <address>
        <city>Oradell</city>
        <state>New Jersey</state>
        <zip>07649</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates, LLP</name>
      <address>
        <city>Bayside</city>
        <state>New York</state>
        <zip>11360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates, LLP</name>
      <address>
        <city>Middletown</city>
        <state>New York</state>
        <zip>10941</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates, LLP</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Ear, Nose and Throat Associates</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear, Nose and Throat Associates of Texas</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2017</study_first_submitted>
  <study_first_submitted_qc>September 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2017</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nasal valve</keyword>
  <keyword>Nasal airway obstruction</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Airway Obstruction</mesh_term>
    <mesh_term>Nasal Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

